Sign In
Buy LQDA
$75.49
+4.42 (+6.22%)
At Close: Jun 22, 2026
Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript
06:22pm, Tuesday, 16'th Jun 2026
Liquidia Corporation (LQDA) Shareholder/Analyst Call Prepared Remarks Transcript
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?
04:42pm, Monday, 15'th Jun 2026
Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take different paths to sector exposure.
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
08:30am, Thursday, 11'th Jun 2026
MORRISVILLE, N.C., June 11, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challengi
Liquidia Corp (LQDA) Stock Up 3.4% and Still Undervalued -- GF Score: 75/100
07:24pm, Monday, 08'th Jun 2026
On June 08, 2026, Liquidia Corp (LQDA) shares rose 3.4% today, continuing a strong performance within a 52-week range of $11.85 to $66.78. The stock has shown i
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
08:30am, Monday, 08'th Jun 2026
MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challengi
4 Best Low-Beta Stocks to Buy Right Away: LQDA, CVX, OXY & VLO
12:15pm, Friday, 05'th Jun 2026
Fragile Iran ceasefire keeps stocks volatile. Low-beta picks LQDA, CVX, OXY and VLO show recent gains and solid volume.
4 Biotech Stocks Investors Should Watch in 2026
11:55am, Friday, 05'th Jun 2026
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and soli
State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
01:13pm, Thursday, 04'th Jun 2026
Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration-key factors shaping their long-term investor appeal.
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?
11:16am, Thursday, 04'th Jun 2026
Compare diversification strategies and see how each ETF's unique index focus shapes risk and return for healthcare sector investors.
Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice
01:01pm, Thursday, 28'th May 2026
Does Liquidia Corporation (LQDA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
08:30am, Wednesday, 27'th May 2026
MORRISVILLE, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and C
4 Low-Beta Stocks for a Steadier Portfolio: LQDA, XOM, VLO & FANG
12:46pm, Wednesday, 20'th May 2026
Middle East tensions are stoking volatility; a low-beta screen spotlights Liquidia, Exxon Mobil, Valero Energy and Diamondback Energy.
Earnings Estimates Moving Higher for Liquidia Corporation (LQDA): Time to Buy?
01:21pm, Thursday, 14'th May 2026
Liquidia Corporation (LQDA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Liquidia Corporation (LQDA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:00pm, Wednesday, 13'th May 2026
Liquidia Corporation (LQDA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
What to Know About This Fund’s $15.5 Million Sale of Liquidia as Shares Skyrocket Nearly 260%
12:23pm, Wednesday, 13'th May 2026
Liquidia develops therapies for rare cardiopulmonary diseases, leveraging proprietary drug delivery technologies in the U.S. market.
